

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | desmosome organization (GO:0002934) | 7.53464517 |
| 2 | hemidesmosome assembly (GO:0031581) | 7.21092445 |
| 3 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 6.83974972 |
| 4 | activation of Rac GTPase activity (GO:0032863) | 5.30452888 |
| 5 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 5.20861833 |
| 6 | regulation of water loss via skin (GO:0033561) | 4.63345893 |
| 7 | establishment of skin barrier (GO:0061436) | 4.49280623 |
| 8 | regulation of apoptotic cell clearance (GO:2000425) | 4.34160238 |
| 9 | COPI coating of Golgi vesicle (GO:0048205) | 4.30591915 |
| 10 | Golgi transport vesicle coating (GO:0048200) | 4.30591915 |
| 11 | intestinal absorption (GO:0050892) | 4.07868151 |
| 12 | renal filtration (GO:0097205) | 4.01719729 |
| 13 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.99728968 |
| 14 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 3.91823126 |
| 15 | keratinization (GO:0031424) | 3.90419412 |
| 16 | apoptotic cell clearance (GO:0043277) | 3.88661007 |
| 17 | positive regulation of pseudopodium assembly (GO:0031274) | 3.85581703 |
| 18 | O-glycan processing (GO:0016266) | 3.83435438 |
| 19 | citrulline biosynthetic process (GO:0019240) | 3.80873583 |
| 20 | semaphorin-plexin signaling pathway (GO:0071526) | 3.77122902 |
| 21 | epithelial cell-cell adhesion (GO:0090136) | 3.70967438 |
| 22 | complement activation, alternative pathway (GO:0006957) | 3.70801418 |
| 23 | regulation of cholesterol homeostasis (GO:2000188) | 3.68984742 |
| 24 | GDP-mannose metabolic process (GO:0019673) | 3.65566470 |
| 25 | positive regulation of epidermal cell differentiation (GO:0045606) | 3.60226790 |
| 26 | NADH metabolic process (GO:0006734) | 3.47233466 |
| 27 | regulation of integrin activation (GO:0033623) | 3.45780203 |
| 28 | regulation of pseudopodium assembly (GO:0031272) | 3.36084102 |
| 29 | lipoxygenase pathway (GO:0019372) | 3.34768170 |
| 30 | citrulline metabolic process (GO:0000052) | 3.30950712 |
| 31 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.30416258 |
| 32 | low-density lipoprotein particle clearance (GO:0034383) | 3.27086930 |
| 33 | multicellular organismal water homeostasis (GO:0050891) | 3.21088359 |
| 34 | keratinocyte proliferation (GO:0043616) | 3.21007539 |
| 35 | regulation of viral release from host cell (GO:1902186) | 3.16043820 |
| 36 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.15929300 |
| 37 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.15914943 |
| 38 | epithelial structure maintenance (GO:0010669) | 3.15796829 |
| 39 | protein autoprocessing (GO:0016540) | 3.14955145 |
| 40 | peptide cross-linking (GO:0018149) | 3.14156736 |
| 41 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 3.13961121 |
| 42 | cell-substrate junction assembly (GO:0007044) | 3.11560687 |
| 43 | mannose metabolic process (GO:0006013) | 3.11182896 |
| 44 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 3.10406433 |
| 45 | white fat cell differentiation (GO:0050872) | 3.10317208 |
| 46 | phospholipid efflux (GO:0033700) | 3.10015556 |
| 47 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.09156091 |
| 48 | protein retention in ER lumen (GO:0006621) | 3.08995048 |
| 49 | keratinocyte differentiation (GO:0030216) | 3.08651596 |
| 50 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.08010542 |
| 51 | proline biosynthetic process (GO:0006561) | 3.07716898 |
| 52 | regulation of guanylate cyclase activity (GO:0031282) | 3.05637496 |
| 53 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.03629883 |
| 54 | leukotriene metabolic process (GO:0006691) | 3.02190631 |
| 55 | regulation of cholesterol storage (GO:0010885) | 3.02109255 |
| 56 | receptor catabolic process (GO:0032801) | 3.02091227 |
| 57 | glomerular filtration (GO:0003094) | 3.00992947 |
| 58 | urea cycle (GO:0000050) | 2.99502239 |
| 59 | bile acid and bile salt transport (GO:0015721) | 2.98663315 |
| 60 | regulation of cholesterol transport (GO:0032374) | 2.96259617 |
| 61 | regulation of sterol transport (GO:0032371) | 2.96259617 |
| 62 | regulation of keratinocyte differentiation (GO:0045616) | 2.96186407 |
| 63 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.95442316 |
| 64 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.94503503 |
| 65 | mesodermal cell differentiation (GO:0048333) | 2.93602017 |
| 66 | surfactant homeostasis (GO:0043129) | 2.93206518 |
| 67 | lung epithelium development (GO:0060428) | 2.93143773 |
| 68 | tight junction assembly (GO:0070830) | 2.93047563 |
| 69 | gap junction assembly (GO:0016264) | 2.92369261 |
| 70 | regulation of phospholipase A2 activity (GO:0032429) | 2.89615035 |
| 71 | artery development (GO:0060840) | 2.88834444 |
| 72 | negative regulation of viral release from host cell (GO:1902187) | 2.88788230 |
| 73 | renal system process involved in regulation of blood volume (GO:0001977) | 2.87781252 |
| 74 | sphingoid metabolic process (GO:0046519) | 2.87588152 |
| 75 | intestinal epithelial cell development (GO:0060576) | 2.86267459 |
| 76 | intermediate filament organization (GO:0045109) | 2.85533400 |
| 77 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.84212881 |
| 78 | regulation of Cdc42 GTPase activity (GO:0043088) | 2.83987104 |
| 79 | angiotensin maturation (GO:0002003) | 2.82275239 |
| 80 | positive regulation of establishment of protein localization to plasma membrane (GO:0090004) | 2.81611326 |
| 81 | brown fat cell differentiation (GO:0050873) | 2.81377758 |
| 82 | intestinal cholesterol absorption (GO:0030299) | 2.80274937 |
| 83 | cell communication involved in cardiac conduction (GO:0086065) | 2.79834388 |
| 84 | apoptotic process involved in morphogenesis (GO:0060561) | 2.79784887 |
| 85 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.79150742 |
| 86 | vitamin transmembrane transport (GO:0035461) | 2.78183127 |
| 87 | diol metabolic process (GO:0034311) | 2.78087320 |
| 88 | endothelial cell chemotaxis (GO:0035767) | 2.76524058 |
| 89 | lipoprotein transport (GO:0042953) | 2.76376452 |
| 90 | urea metabolic process (GO:0019627) | 2.73254878 |
| 91 | establishment of apical/basal cell polarity (GO:0035089) | 2.72421614 |
| 92 | regulation of cholesterol efflux (GO:0010874) | 2.72139924 |
| 93 | positive regulation of cholesterol efflux (GO:0010875) | 2.72044534 |
| 94 | regulation of keratinocyte proliferation (GO:0010837) | 2.71740841 |
| 95 | cell-cell junction assembly (GO:0007043) | 2.71620467 |
| 96 | cGMP-mediated signaling (GO:0019934) | 2.69115452 |
| 97 | skin morphogenesis (GO:0043589) | 2.66426450 |
| 98 | focal adhesion assembly (GO:0048041) | 2.66328529 |
| 99 | cell-substrate adherens junction assembly (GO:0007045) | 2.66328529 |
| 100 | sulfate transmembrane transport (GO:1902358) | 2.65806553 |
| 101 | virion attachment to host cell (GO:0019062) | 2.65763192 |
| 102 | adhesion of symbiont to host cell (GO:0044650) | 2.65763192 |
| 103 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.64734950 |
| 104 | positive regulation of protein localization to plasma membrane (GO:1903078) | 2.64311698 |
| 105 | regulation of macrophage chemotaxis (GO:0010758) | 2.64247908 |
| 106 | water homeostasis (GO:0030104) | 2.64039773 |
| 107 | atrioventricular valve morphogenesis (GO:0003181) | 2.62648982 |
| 108 | adherens junction assembly (GO:0034333) | 2.61914489 |
| 109 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.61686096 |
| 110 | sphingosine metabolic process (GO:0006670) | 2.60970315 |
| 111 | regulation of cardioblast differentiation (GO:0051890) | 2.60851456 |
| 112 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.60685610 |
| 113 | phospholipid scrambling (GO:0017121) | 2.59412723 |
| 114 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.59037856 |
| 115 | cyclooxygenase pathway (GO:0019371) | 2.58401286 |
| 116 | actin filament depolymerization (GO:0030042) | 2.58039939 |
| 117 | amyloid precursor protein metabolic process (GO:0042982) | 2.58032496 |
| 118 | peptide catabolic process (GO:0043171) | 2.57736542 |
| 119 | chondrocyte proliferation (GO:0035988) | 2.57718030 |
| 120 | filopodium assembly (GO:0046847) | 2.56946333 |
| 121 | positive regulation of fatty acid oxidation (GO:0046321) | 2.56929920 |
| 122 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.56912993 |
| 123 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.55851829 |
| 124 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.55833059 |
| 125 | positive regulation of cholesterol transport (GO:0032376) | 2.55492976 |
| 126 | positive regulation of sterol transport (GO:0032373) | 2.55492976 |
| 127 | morphogenesis of embryonic epithelium (GO:0016331) | 2.54930854 |
| 128 | regulation of endothelial cell chemotaxis (GO:2001026) | 2.54247600 |
| 129 | negative regulation of protein autophosphorylation (GO:0031953) | 2.53807951 |
| 130 | vitamin A metabolic process (GO:0006776) | 2.53619865 |
| 131 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.53448302 |
| 132 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.52319718 |
| 133 | cellular response to lithium ion (GO:0071285) | 2.51884778 |
| 134 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.49584666 |
| 135 | epidermal cell differentiation (GO:0009913) | 2.49363674 |
| 136 | positive regulation of p38MAPK cascade (GO:1900745) | 2.49074325 |
| 137 | hypotonic response (GO:0006971) | 2.48840582 |
| 138 | barbed-end actin filament capping (GO:0051016) | 2.48582656 |
| 139 | regulation of T cell tolerance induction (GO:0002664) | 2.47631467 |
| 140 | extracellular matrix assembly (GO:0085029) | 2.47356948 |
| 141 | cell volume homeostasis (GO:0006884) | 2.47324802 |
| 142 | positive regulation of receptor recycling (GO:0001921) | 2.46744565 |
| 143 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.46432313 |
| 144 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.45703985 |
| 145 | glutathione biosynthetic process (GO:0006750) | 2.44963944 |
| 146 | regulation of histone phosphorylation (GO:0033127) | 2.44616414 |
| 147 | carnitine shuttle (GO:0006853) | 2.44392695 |
| 148 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.44225408 |
| 149 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.44225408 |
| 150 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.43940236 |
| 151 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.43875857 |
| 152 | mammary gland epithelial cell proliferation (GO:0033598) | 2.43631859 |
| 153 | positive regulation of epidermis development (GO:0045684) | 2.43533439 |
| 154 | regulation of p38MAPK cascade (GO:1900744) | 2.43526324 |
| 155 | protein heterotrimerization (GO:0070208) | 2.42986272 |
| 156 | negative regulation of myotube differentiation (GO:0010832) | 2.42131557 |
| 157 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.41982185 |
| 158 | arachidonic acid metabolic process (GO:0019369) | 2.41683465 |
| 159 | negative regulation of cholesterol transport (GO:0032375) | 2.41413213 |
| 160 | negative regulation of sterol transport (GO:0032372) | 2.41413213 |
| 161 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.40352826 |
| 162 | renal system development (GO:0072001) | 2.40343000 |
| 163 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.39920456 |
| 164 | digestive system process (GO:0022600) | 2.39160385 |
| 165 | phosphatidylethanolamine metabolic process (GO:0046337) | 2.38490704 |
| 166 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.37950235 |
| 167 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.37039967 |
| 168 | ectoderm development (GO:0007398) | 2.35504685 |
| 169 | regulation of sequestering of triglyceride (GO:0010889) | 2.34813279 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.30342395 |
| 2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.28998002 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.24943693 |
| 4 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.61714033 |
| 5 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.41582559 |
| 6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.31932337 |
| 7 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.09312612 |
| 8 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.01838588 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 10.4180518 |
| 10 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.97792647 |
| 11 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.95641325 |
| 12 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.95311444 |
| 13 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.92322387 |
| 14 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.91746946 |
| 15 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.89419169 |
| 16 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.81929155 |
| 17 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.78358345 |
| 18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.77213770 |
| 19 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.73595263 |
| 20 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.73227325 |
| 21 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.63358579 |
| 22 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.61166057 |
| 23 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.60684232 |
| 24 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.59661299 |
| 25 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.59182929 |
| 26 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.58830604 |
| 27 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.58559718 |
| 28 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.55923248 |
| 29 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.55835184 |
| 30 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.52451785 |
| 31 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.51494985 |
| 32 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.50418416 |
| 33 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.46614358 |
| 34 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.46053654 |
| 35 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.45112019 |
| 36 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.43212472 |
| 37 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.43149267 |
| 38 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.43014024 |
| 39 | P68_20966046_ChIP-Seq_HELA_Human | 1.41742233 |
| 40 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.40938513 |
| 41 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.40938513 |
| 42 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.40788367 |
| 43 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.39634126 |
| 44 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.35257163 |
| 45 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.32756123 |
| 46 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.31643838 |
| 47 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.30996187 |
| 48 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.28570793 |
| 49 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.27927201 |
| 50 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.27027653 |
| 51 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26778595 |
| 52 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.24794314 |
| 53 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.23948782 |
| 54 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.22078635 |
| 55 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.21942379 |
| 56 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.20682201 |
| 57 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.20667059 |
| 58 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.18970004 |
| 59 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.18511917 |
| 60 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.18333168 |
| 61 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.17767724 |
| 62 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.17223462 |
| 63 | CJUN_26792858_Chip-Seq_BT549_Human | 1.17196048 |
| 64 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.16230462 |
| 65 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15865991 |
| 66 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.15823664 |
| 67 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.13602409 |
| 68 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.12324859 |
| 69 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.12221727 |
| 70 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.12072546 |
| 71 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11297094 |
| 72 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.10873808 |
| 73 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09165889 |
| 74 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.09138768 |
| 75 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.05828465 |
| 76 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.05537866 |
| 77 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.05062127 |
| 78 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.03908667 |
| 79 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.03536194 |
| 80 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.03253846 |
| 81 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.02234169 |
| 82 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.01395836 |
| 83 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.00242886 |
| 84 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.99679695 |
| 85 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.99539415 |
| 86 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.99417560 |
| 87 | GATA1_22025678_ChIP-Seq_K562_Human | 0.99000896 |
| 88 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.98147937 |
| 89 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.97933583 |
| 90 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.97568598 |
| 91 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97388696 |
| 92 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.96899616 |
| 93 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.96708281 |
| 94 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.95863853 |
| 95 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.95639086 |
| 96 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.95184796 |
| 97 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93866967 |
| 98 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.93496818 |
| 99 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.93230530 |
| 100 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.92489526 |
| 101 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.91880930 |
| 102 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.91792906 |
| 103 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.91769877 |
| 104 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.91581588 |
| 105 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.90828547 |
| 106 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.90652534 |
| 107 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.90381361 |
| 108 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.90165978 |
| 109 | KDM2B_26808549_Chip-Seq_K562_Human | 0.90014345 |
| 110 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.89462223 |
| 111 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.87829146 |
| 112 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.86407933 |
| 113 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86396694 |
| 114 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.85065193 |
| 115 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.84811990 |
| 116 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.84216970 |
| 117 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.83749928 |
| 118 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.83433497 |
| 119 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83046444 |
| 120 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.82605784 |
| 121 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.82133039 |
| 122 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81501124 |
| 123 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.81450874 |
| 124 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.78567468 |
| 125 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.76509726 |
| 126 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.76114258 |
| 127 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.75803090 |
| 128 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.75752083 |
| 129 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.75214391 |
| 130 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.75078133 |
| 131 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.74770772 |
| 132 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.73701191 |
| 133 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.72819173 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 4.48207209 |
| 2 | MP0005275_abnormal_skin_tensile | 4.27255003 |
| 3 | MP0002796_impaired_skin_barrier | 4.18359252 |
| 4 | MP0005377_hearing/vestibular/ear_phenot | 3.70250118 |
| 5 | MP0003878_abnormal_ear_physiology | 3.70250118 |
| 6 | MP0002822_catalepsy | 3.54737206 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 3.45807641 |
| 8 | MP0000566_synostosis | 3.11541699 |
| 9 | MP0002060_abnormal_skin_morphology | 2.89807764 |
| 10 | MP0002254_reproductive_system_inflammat | 2.87666647 |
| 11 | MP0008438_abnormal_cutaneous_collagen | 2.87013644 |
| 12 | MP0005670_abnormal_white_adipose | 2.62395601 |
| 13 | MP0003941_abnormal_skin_development | 2.56043180 |
| 14 | MP0004185_abnormal_adipocyte_glucose | 2.54120980 |
| 15 | MP0005409_darkened_coat_color | 2.36537178 |
| 16 | MP0005501_abnormal_skin_physiology | 2.34770304 |
| 17 | MP0008004_abnormal_stomach_pH | 2.26181099 |
| 18 | MP0000678_abnormal_parathyroid_gland | 2.22183008 |
| 19 | MP0001666_abnormal_nutrient_absorption | 2.21658913 |
| 20 | MP0005257_abnormal_intraocular_pressure | 2.10943389 |
| 21 | MP0001216_abnormal_epidermal_layer | 2.10842698 |
| 22 | MP0004947_skin_inflammation | 2.07482912 |
| 23 | MP0003283_abnormal_digestive_organ | 2.07259279 |
| 24 | MP0003566_abnormal_cell_adhesion | 1.98074495 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 1.94956073 |
| 26 | MP0004782_abnormal_surfactant_physiolog | 1.93781964 |
| 27 | MP0001873_stomach_inflammation | 1.90682668 |
| 28 | MP0005360_urolithiasis | 1.87713650 |
| 29 | MP0005167_abnormal_blood-brain_barrier | 1.76468696 |
| 30 | MP0010771_integument_phenotype | 1.76096778 |
| 31 | MP0000013_abnormal_adipose_tissue | 1.73100239 |
| 32 | MP0000467_abnormal_esophagus_morphology | 1.72509284 |
| 33 | MP0000579_abnormal_nail_morphology | 1.68286490 |
| 34 | MP0002877_abnormal_melanocyte_morpholog | 1.67012266 |
| 35 | MP0005451_abnormal_body_composition | 1.65914594 |
| 36 | MP0005083_abnormal_biliary_tract | 1.64664385 |
| 37 | MP0004272_abnormal_basement_membrane | 1.63870797 |
| 38 | MP0003453_abnormal_keratinocyte_physiol | 1.63270662 |
| 39 | MP0010678_abnormal_skin_adnexa | 1.62977840 |
| 40 | MP0001849_ear_inflammation | 1.60913760 |
| 41 | MP0005666_abnormal_adipose_tissue | 1.57716824 |
| 42 | MP0000462_abnormal_digestive_system | 1.55985190 |
| 43 | MP0004264_abnormal_extraembryonic_tissu | 1.55191079 |
| 44 | MP0003724_increased_susceptibility_to | 1.42295293 |
| 45 | MP0008875_abnormal_xenobiotic_pharmacok | 1.41651923 |
| 46 | MP0010352_gastrointestinal_tract_polyps | 1.40178583 |
| 47 | MP0000383_abnormal_hair_follicle | 1.40168970 |
| 48 | MP0003866_abnormal_defecation | 1.37089183 |
| 49 | MP0003300_gastrointestinal_ulcer | 1.33371211 |
| 50 | MP0000537_abnormal_urethra_morphology | 1.33162863 |
| 51 | MP0001664_abnormal_digestion | 1.31663450 |
| 52 | MP0010329_abnormal_lipoprotein_level | 1.30059547 |
| 53 | MP0002098_abnormal_vibrissa_morphology | 1.29382596 |
| 54 | MP0003806_abnormal_nucleotide_metabolis | 1.27843111 |
| 55 | MP0003183_abnormal_peptide_metabolism | 1.26927095 |
| 56 | MP0009379_abnormal_foot_pigmentation | 1.26465230 |
| 57 | MP0005058_abnormal_lysosome_morphology | 1.24099532 |
| 58 | MP0000516_abnormal_urinary_system | 1.23951357 |
| 59 | MP0005367_renal/urinary_system_phenotyp | 1.23951357 |
| 60 | MP0001663_abnormal_digestive_system | 1.20424159 |
| 61 | MP0005381_digestive/alimentary_phenotyp | 1.20414929 |
| 62 | MP0004019_abnormal_vitamin_homeostasis | 1.19957404 |
| 63 | MP0004130_abnormal_muscle_cell | 1.16387553 |
| 64 | MP0005375_adipose_tissue_phenotype | 1.15098904 |
| 65 | MP0000858_altered_metastatic_potential | 1.12703559 |
| 66 | MP0005023_abnormal_wound_healing | 1.12400384 |
| 67 | MP0000762_abnormal_tongue_morphology | 1.11581545 |
| 68 | MP0008260_abnormal_autophagy | 1.11298347 |
| 69 | MP0000377_abnormal_hair_follicle | 1.10850481 |
| 70 | MP0004858_abnormal_nervous_system | 1.10006333 |
| 71 | MP0009931_abnormal_skin_appearance | 1.09656541 |
| 72 | MP0003693_abnormal_embryo_hatching | 1.09612895 |
| 73 | MP0005365_abnormal_bile_salt | 1.09480234 |
| 74 | MP0000627_abnormal_mammary_gland | 1.08788126 |
| 75 | MP0000538_abnormal_urinary_bladder | 1.08742656 |
| 76 | MP0009384_cardiac_valve_regurgitation | 1.08249489 |
| 77 | MP0005076_abnormal_cell_differentiation | 1.08006314 |
| 78 | MP0000477_abnormal_intestine_morphology | 1.06940663 |
| 79 | MP0002139_abnormal_hepatobiliary_system | 1.04810227 |
| 80 | MP0010155_abnormal_intestine_physiology | 1.03170065 |
| 81 | MP0006054_spinal_hemorrhage | 1.02331502 |
| 82 | MP0000647_abnormal_sebaceous_gland | 1.00102034 |
| 83 | MP0009053_abnormal_anal_canal | 0.96310620 |
| 84 | MP0000003_abnormal_adipose_tissue | 0.96234780 |
| 85 | MP0001243_abnormal_dermal_layer | 0.95820964 |
| 86 | MP0002166_altered_tumor_susceptibility | 0.95484570 |
| 87 | MP0001348_abnormal_lacrimal_gland | 0.94891297 |
| 88 | MP0003315_abnormal_perineum_morphology | 0.94430123 |
| 89 | MP0009840_abnormal_foam_cell | 0.91076687 |
| 90 | MP0002909_abnormal_adrenal_gland | 0.91008781 |
| 91 | MP0001533_abnormal_skeleton_physiology | 0.90970553 |
| 92 | MP0002896_abnormal_bone_mineralization | 0.90168278 |
| 93 | MP0000427_abnormal_hair_cycle | 0.90074684 |
| 94 | MP0001191_abnormal_skin_condition | 0.89850370 |
| 95 | MP0003091_abnormal_cell_migration | 0.88715821 |
| 96 | MP0000751_myopathy | 0.87172758 |
| 97 | MP0002249_abnormal_larynx_morphology | 0.86346301 |
| 98 | MP0009780_abnormal_chondrocyte_physiolo | 0.86034380 |
| 99 | MP0003436_decreased_susceptibility_to | 0.81303753 |
| 100 | MP0004043_abnormal_pH_regulation | 0.80512715 |
| 101 | MP0004381_abnormal_hair_follicle | 0.78726305 |
| 102 | MP0002089_abnormal_postnatal_growth/wei | 0.78284363 |
| 103 | MP0003045_fibrosis | 0.76519106 |
| 104 | MP0002136_abnormal_kidney_physiology | 0.75736635 |
| 105 | MP0005503_abnormal_tendon_morphology | 0.74523264 |
| 106 | MP0001851_eye_inflammation | 0.74484957 |
| 107 | MP0004957_abnormal_blastocyst_morpholog | 0.73791721 |
| 108 | MP0001881_abnormal_mammary_gland | 0.73775373 |
| 109 | MP0000465_gastrointestinal_hemorrhage | 0.73410047 |
| 110 | MP0002971_abnormal_brown_adipose | 0.72061717 |
| 111 | MP0000490_abnormal_crypts_of | 0.71771937 |
| 112 | MP0001765_abnormal_ion_homeostasis | 0.71527276 |
| 113 | MP0002118_abnormal_lipid_homeostasis | 0.71079276 |
| 114 | MP0002006_tumorigenesis | 0.70800645 |
| 115 | MP0000470_abnormal_stomach_morphology | 0.70349654 |
| 116 | MP0009115_abnormal_fat_cell | 0.70056308 |
| 117 | MP0010030_abnormal_orbit_morphology | 0.69988315 |
| 118 | MP0005085_abnormal_gallbladder_physiolo | 0.69485420 |
| 119 | MP0001756_abnormal_urination | 0.66169966 |
| 120 | MP0005165_increased_susceptibility_to | 0.65629461 |
| 121 | MP0009643_abnormal_urine_homeostasis | 0.65105187 |
| 122 | MP0006138_congestive_heart_failure | 0.63921383 |
| 123 | MP0003075_altered_response_to | 0.63753833 |
| 124 | MP0004484_altered_response_of | 0.63520773 |
| 125 | MP0003950_abnormal_plasma_membrane | 0.63261054 |
| 126 | MP0005390_skeleton_phenotype | 0.63218181 |
| 127 | MP0003385_abnormal_body_wall | 0.61668453 |
| 128 | MP0002086_abnormal_extraembryonic_tissu | 0.60285740 |
| 129 | MP0001958_emphysema | 0.58782739 |
| 130 | MP0005166_decreased_susceptibility_to | 0.55070334 |
| 131 | MP0000367_abnormal_coat/_hair | 0.54962732 |
| 132 | MP0001730_embryonic_growth_arrest | 0.54379518 |
| 133 | MP0005621_abnormal_cell_physiology | 0.51264199 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Right ventricular cardiomyopathy (HP:0011663) | 6.97964539 |
| 2 | Milia (HP:0001056) | 4.97887635 |
| 3 | Atrophic scars (HP:0001075) | 4.52726896 |
| 4 | Plantar hyperkeratosis (HP:0007556) | 4.18290954 |
| 5 | Fragile nails (HP:0001808) | 4.11807447 |
| 6 | Systemic lupus erythematosus (HP:0002725) | 4.11787795 |
| 7 | Woolly hair (HP:0002224) | 4.02897515 |
| 8 | Malnutrition (HP:0004395) | 3.99650217 |
| 9 | Onycholysis (HP:0001806) | 3.95306848 |
| 10 | Hyperactive renin-angiotensin system (HP:0000841) | 3.84170597 |
| 11 | Pustule (HP:0200039) | 3.59629042 |
| 12 | Flat acetabular roof (HP:0003180) | 3.46253258 |
| 13 | Ventricular tachycardia (HP:0004756) | 3.39635943 |
| 14 | Oligomenorrhea (HP:0000876) | 3.39252319 |
| 15 | Distal lower limb amyotrophy (HP:0008944) | 3.38894070 |
| 16 | Fragile skin (HP:0001030) | 3.35092286 |
| 17 | Broad face (HP:0000283) | 3.34905719 |
| 18 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.32628369 |
| 19 | Prostate neoplasm (HP:0100787) | 3.26097810 |
| 20 | Ileus (HP:0002595) | 3.23953226 |
| 21 | Pili torti (HP:0003777) | 3.20763101 |
| 22 | Palmoplantar hyperkeratosis (HP:0000972) | 3.15690496 |
| 23 | Hypotrichosis (HP:0001006) | 3.13005914 |
| 24 | Focal segmental glomerulosclerosis (HP:0000097) | 3.12616524 |
| 25 | Alopecia of scalp (HP:0002293) | 3.06038935 |
| 26 | Increased connective tissue (HP:0009025) | 3.03576033 |
| 27 | Ankyloglossia (HP:0010296) | 3.03242923 |
| 28 | Abnormality of complement system (HP:0005339) | 2.99237294 |
| 29 | Acanthosis nigricans (HP:0000956) | 2.98893559 |
| 30 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.98446485 |
| 31 | Increased IgE level (HP:0003212) | 2.93606999 |
| 32 | Ridged nail (HP:0001807) | 2.92907561 |
| 33 | Hemorrhage of the eye (HP:0011885) | 2.91205689 |
| 34 | Pterygium (HP:0001059) | 2.88682743 |
| 35 | Upper limb amyotrophy (HP:0009129) | 2.86940703 |
| 36 | Distal upper limb amyotrophy (HP:0007149) | 2.86940703 |
| 37 | Shallow orbits (HP:0000586) | 2.86000759 |
| 38 | Broad metatarsal (HP:0001783) | 2.84786110 |
| 39 | Palmar hyperkeratosis (HP:0010765) | 2.84141739 |
| 40 | Complement deficiency (HP:0004431) | 2.78469880 |
| 41 | Glomerulosclerosis (HP:0000096) | 2.77347648 |
| 42 | Lip pit (HP:0100267) | 2.65291666 |
| 43 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.64900935 |
| 44 | Short nail (HP:0001799) | 2.62107282 |
| 45 | Toxemia of pregnancy (HP:0100603) | 2.58070958 |
| 46 | Polygenic inheritance (HP:0010982) | 2.57411653 |
| 47 | Abnormality of nail color (HP:0100643) | 2.57361489 |
| 48 | Glomerulonephritis (HP:0000099) | 2.57000678 |
| 49 | Thick nail (HP:0001805) | 2.55523215 |
| 50 | Abnormal blistering of the skin (HP:0008066) | 2.55363181 |
| 51 | Conjunctival hamartoma (HP:0100780) | 2.54331698 |
| 52 | Neonatal short-limb short stature (HP:0008921) | 2.51166846 |
| 53 | Nail dystrophy (HP:0008404) | 2.51046032 |
| 54 | Trismus (HP:0000211) | 2.48150634 |
| 55 | Selective tooth agenesis (HP:0001592) | 2.44927535 |
| 56 | Short hallux (HP:0010109) | 2.43301806 |
| 57 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.41938395 |
| 58 | Hyperacusis (HP:0010780) | 2.41711257 |
| 59 | Abnormality of the 1st metacarpal (HP:0010009) | 2.36484950 |
| 60 | Cerebral aneurysm (HP:0004944) | 2.35081290 |
| 61 | Sparse eyelashes (HP:0000653) | 2.34343887 |
| 62 | Axonal loss (HP:0003447) | 2.33554108 |
| 63 | Bronchomalacia (HP:0002780) | 2.32917640 |
| 64 | Cupped ribs (HP:0000887) | 2.30481909 |
| 65 | Abnormality of oral frenula (HP:0000190) | 2.30147721 |
| 66 | Vacuolated lymphocytes (HP:0001922) | 2.29774103 |
| 67 | Aortic dissection (HP:0002647) | 2.26758856 |
| 68 | Distal lower limb muscle weakness (HP:0009053) | 2.26453596 |
| 69 | Abnormality of the 2nd finger (HP:0004100) | 2.25649116 |
| 70 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.24668329 |
| 71 | Peritonitis (HP:0002586) | 2.24548344 |
| 72 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.23688625 |
| 73 | Aplasia cutis congenita (HP:0001057) | 2.22295612 |
| 74 | Thin bony cortex (HP:0002753) | 2.22238484 |
| 75 | Villous atrophy (HP:0011473) | 2.22207085 |
| 76 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.22207085 |
| 77 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.21204147 |
| 78 | Follicular hyperkeratosis (HP:0007502) | 2.20948021 |
| 79 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.19744958 |
| 80 | Interstitial pulmonary disease (HP:0006530) | 2.19044686 |
| 81 | Nephritis (HP:0000123) | 2.17565400 |
| 82 | Congenital, generalized hypertrichosis (HP:0004540) | 2.17440947 |
| 83 | Type 1 muscle fiber predominance (HP:0003803) | 2.15075362 |
| 84 | Premature rupture of membranes (HP:0001788) | 2.14244501 |
| 85 | Abnormality of carpal bone ossification (HP:0006257) | 2.13304975 |
| 86 | Abnormality of proline metabolism (HP:0010907) | 2.12216676 |
| 87 | Hydroxyprolinuria (HP:0003080) | 2.12216676 |
| 88 | Protrusio acetabuli (HP:0003179) | 2.11936189 |
| 89 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.11691448 |
| 90 | Wrist flexion contracture (HP:0001239) | 2.10526313 |
| 91 | Advanced eruption of teeth (HP:0006288) | 2.07513895 |
| 92 | Abdominal distention (HP:0003270) | 2.06126088 |
| 93 | Cervical subluxation (HP:0003308) | 2.05935384 |
| 94 | Abnormality of chloride homeostasis (HP:0011422) | 2.04781617 |
| 95 | Flattened epiphyses (HP:0003071) | 2.04494724 |
| 96 | Lower limb amyotrophy (HP:0007210) | 2.03660832 |
| 97 | Premature loss of primary teeth (HP:0006323) | 2.01243733 |
| 98 | Deviation of the thumb (HP:0009603) | 2.01078687 |
| 99 | Hypoplasia of dental enamel (HP:0006297) | 2.00793679 |
| 100 | Ankle contracture (HP:0006466) | 2.00406225 |
| 101 | Ventricular fibrillation (HP:0001663) | 1.99991265 |
| 102 | Hoarse voice (HP:0001609) | 1.98581309 |
| 103 | Osteolytic defects of the hand bones (HP:0009699) | 1.98571696 |
| 104 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.98571696 |
| 105 | Hyperkalemia (HP:0002153) | 1.98159207 |
| 106 | Abnormality of renin-angiotensin system (HP:0000847) | 1.97789056 |
| 107 | Dehydration (HP:0001944) | 1.97434280 |
| 108 | Hyporeflexia of lower limbs (HP:0002600) | 1.97271138 |
| 109 | Abnormality of the salivary glands (HP:0010286) | 1.96969112 |
| 110 | Xanthomatosis (HP:0000991) | 1.96134480 |
| 111 | Spinal cord compression (HP:0002176) | 1.96131896 |
| 112 | Abnormal ossification of hand bones (HP:0005921) | 1.96128315 |
| 113 | Hypoalphalipoproteinemia (HP:0003233) | 1.93288252 |
| 114 | Cheilitis (HP:0100825) | 1.92144808 |
| 115 | Aortic aneurysm (HP:0004942) | 1.91395635 |
| 116 | Natal tooth (HP:0000695) | 1.91306105 |
| 117 | Ureteral stenosis (HP:0000071) | 1.90092998 |
| 118 | Amelogenesis imperfecta (HP:0000705) | 1.88105834 |
| 119 | Abnormal cartilage morphology (HP:0002763) | 1.87363081 |
| 120 | Short phalanx of the thumb (HP:0009660) | 1.86597155 |
| 121 | Oligodontia (HP:0000677) | 1.85284527 |
| 122 | Mesangial abnormality (HP:0001966) | 1.85026293 |
| 123 | Curly hair (HP:0002212) | 1.82736641 |
| 124 | Rectal prolapse (HP:0002035) | 1.82614182 |
| 125 | Autoimmune thrombocytopenia (HP:0001973) | 1.82592280 |
| 126 | Popliteal pterygium (HP:0009756) | 1.81828042 |
| 127 | Abnormal hair laboratory examination (HP:0003328) | 1.81701162 |
| 128 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.80696866 |
| 129 | Vertebral hypoplasia (HP:0008417) | 1.80696866 |
| 130 | Erythema (HP:0010783) | 1.79948547 |
| 131 | Neonatal death (HP:0003811) | 1.79897130 |
| 132 | Hyponatremia (HP:0002902) | 1.78597253 |
| 133 | Dysostosis multiplex (HP:0000943) | 1.77715306 |
| 134 | Breech presentation (HP:0001623) | 1.77380577 |
| 135 | Absent phalangeal crease (HP:0006109) | 1.76918229 |
| 136 | Abnormal vertebral ossification (HP:0100569) | 1.76139406 |
| 137 | Multifactorial inheritance (HP:0001426) | 1.75645792 |
| 138 | Blepharitis (HP:0000498) | 1.73860729 |
| 139 | Abnormal hand bone ossification (HP:0010660) | 1.72814453 |
| 140 | Conjugated hyperbilirubinemia (HP:0002908) | 1.72264899 |
| 141 | Parakeratosis (HP:0001036) | 1.72037927 |
| 142 | Hyperparathyroidism (HP:0000843) | 1.71978723 |
| 143 | Ectropion (HP:0000656) | 1.71731824 |
| 144 | Proximal placement of thumb (HP:0009623) | 1.71650207 |
| 145 | Decreased circulating renin level (HP:0003351) | 1.71053252 |
| 146 | Nasal polyposis (HP:0100582) | 1.69473956 |
| 147 | Bone pain (HP:0002653) | 1.69270199 |
| 148 | Abnormality of the gastric mucosa (HP:0004295) | 1.69050285 |
| 149 | Gastrointestinal dysmotility (HP:0002579) | 1.68949993 |
| 150 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.68921266 |
| 151 | Ureteral obstruction (HP:0006000) | 1.68138699 |
| 152 | Growth hormone excess (HP:0000845) | 1.66133420 |
| 153 | Difficulty climbing stairs (HP:0003551) | 1.65173300 |
| 154 | Progressive hearing impairment (HP:0001730) | 1.64782487 |
| 155 | Polar cataract (HP:0010696) | 1.64185108 |
| 156 | Progressive sensorineural hearing impairment (HP:0000408) | 1.64179080 |
| 157 | Sparse scalp hair (HP:0002209) | 1.61741799 |
| 158 | Diaphragmatic weakness (HP:0009113) | 1.60931460 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PIK3CA | 5.89496940 |
| 2 | MAP3K2 | 4.14692637 |
| 3 | KSR2 | 3.46654819 |
| 4 | MAP2K2 | 3.06172545 |
| 5 | EPHB2 | 3.00244623 |
| 6 | NME1 | 2.76897621 |
| 7 | * MET | 2.66207172 |
| 8 | TRIB3 | 2.63473172 |
| 9 | RIPK1 | 2.58292801 |
| 10 | FRK | 2.44980579 |
| 11 | LMTK2 | 2.38984371 |
| 12 | IRAK3 | 2.21909835 |
| 13 | ERN1 | 2.18187885 |
| 14 | MST4 | 2.02805706 |
| 15 | MAP2K1 | 2.01707970 |
| 16 | EPHA2 | 1.96460049 |
| 17 | EEF2K | 1.90248725 |
| 18 | CAMK1D | 1.89522560 |
| 19 | MAP3K1 | 1.84537114 |
| 20 | TTN | 1.77943084 |
| 21 | FER | 1.76291708 |
| 22 | SMG1 | 1.74265916 |
| 23 | MAPKAPK3 | 1.70701544 |
| 24 | NME2 | 1.61327958 |
| 25 | MYLK | 1.58618574 |
| 26 | PTK6 | 1.57723816 |
| 27 | ICK | 1.55135856 |
| 28 | EPHB1 | 1.40987202 |
| 29 | MAP3K11 | 1.36368418 |
| 30 | MAP3K3 | 1.28143599 |
| 31 | PKN2 | 1.27862242 |
| 32 | CAMK1G | 1.27329763 |
| 33 | DMPK | 1.22748645 |
| 34 | STK39 | 1.21772371 |
| 35 | CDK12 | 1.21458311 |
| 36 | MAP3K12 | 1.17171671 |
| 37 | RET | 1.10892241 |
| 38 | EPHA3 | 1.08098147 |
| 39 | TGFBR2 | 1.06208765 |
| 40 | LRRK2 | 1.03037289 |
| 41 | PRKG2 | 1.02931832 |
| 42 | FGFR4 | 1.00886835 |
| 43 | BMX | 0.99486786 |
| 44 | CDK9 | 0.98621313 |
| 45 | RIPK4 | 0.98503886 |
| 46 | PTK2 | 0.98022447 |
| 47 | LATS1 | 0.97137240 |
| 48 | PIK3CG | 0.94207301 |
| 49 | MAP3K7 | 0.94193503 |
| 50 | TRPM7 | 0.93214931 |
| 51 | TESK1 | 0.92570476 |
| 52 | RPS6KB2 | 0.91612521 |
| 53 | FGFR2 | 0.91311621 |
| 54 | MAP3K6 | 0.87307242 |
| 55 | PBK | 0.84971039 |
| 56 | STK10 | 0.84928792 |
| 57 | GRK6 | 0.84340857 |
| 58 | CDC42BPA | 0.83837106 |
| 59 | SIK1 | 0.83187027 |
| 60 | DDR2 | 0.82399480 |
| 61 | PRPF4B | 0.76667405 |
| 62 | MTOR | 0.75480929 |
| 63 | NTRK1 | 0.75084774 |
| 64 | STK24 | 0.74930244 |
| 65 | WNK4 | 0.74714875 |
| 66 | SIK3 | 0.74614019 |
| 67 | TAOK1 | 0.74567670 |
| 68 | MAP3K10 | 0.73252270 |
| 69 | PRKAA2 | 0.71662803 |
| 70 | FGFR3 | 0.68980225 |
| 71 | MAP3K8 | 0.67913406 |
| 72 | CAMK2D | 0.65248346 |
| 73 | PDK2 | 0.64624284 |
| 74 | BLK | 0.63187519 |
| 75 | TYK2 | 0.62833294 |
| 76 | PDK3 | 0.61830947 |
| 77 | PDK4 | 0.61830947 |
| 78 | FGFR1 | 0.61739200 |
| 79 | MAP3K9 | 0.59838518 |
| 80 | JAK2 | 0.56919693 |
| 81 | PDGFRA | 0.56388300 |
| 82 | STK38 | 0.55571722 |
| 83 | TESK2 | 0.54477095 |
| 84 | ILK | 0.53164209 |
| 85 | EIF2AK1 | 0.51989134 |
| 86 | MAPK15 | 0.51885960 |
| 87 | ERBB2 | 0.50447880 |
| 88 | CSK | 0.50205740 |
| 89 | DAPK2 | 0.49992166 |
| 90 | ACVR1B | 0.49574901 |
| 91 | * MST1R | 0.48968253 |
| 92 | PDPK1 | 0.48743096 |
| 93 | NUAK1 | 0.47716602 |
| 94 | TAOK3 | 0.46836971 |
| 95 | PRKD2 | 0.46244469 |
| 96 | PAK4 | 0.45721222 |
| 97 | NEK6 | 0.45241567 |
| 98 | CDK8 | 0.44807388 |
| 99 | SRC | 0.44572098 |
| 100 | ARAF | 0.43540747 |
| 101 | MAPKAPK2 | 0.42003524 |
| 102 | PAK2 | 0.41286557 |
| 103 | MELK | 0.40715549 |
| 104 | WNK1 | 0.39866611 |
| 105 | CDK7 | 0.38578756 |
| 106 | RPS6KA2 | 0.38191945 |
| 107 | LIMK1 | 0.37438709 |
| 108 | NEK2 | 0.37238848 |
| 109 | MAPKAPK5 | 0.37175094 |
| 110 | MAP3K13 | 0.37114843 |
| 111 | MATK | 0.36657204 |
| 112 | CSF1R | 0.35606381 |
| 113 | DAPK3 | 0.35110889 |
| 114 | PIM2 | 0.35054307 |
| 115 | PRKCH | 0.31291350 |
| 116 | ZAP70 | 0.30988546 |
| 117 | MAPK11 | 0.30861221 |
| 118 | MAP2K6 | 0.30720029 |
| 119 | PRKCI | 0.30257915 |
| 120 | ROCK1 | 0.30151542 |
| 121 | TBK1 | 0.30104081 |
| 122 | MARK2 | 0.29057990 |
| 123 | PTK2B | 0.28607716 |
| 124 | ABL2 | 0.27103979 |
| 125 | CHUK | 0.26210618 |
| 126 | OXSR1 | 0.26160771 |
| 127 | PDK1 | 0.24019757 |
| 128 | TGFBR1 | 0.23652750 |
| 129 | IRAK2 | 0.23611322 |
| 130 | DAPK1 | 0.23178060 |
| 131 | PRKD1 | 0.22902317 |
| 132 | RPS6KA1 | 0.22804699 |
| 133 | LATS2 | 0.22785322 |
| 134 | ERBB4 | 0.22260589 |
| 135 | STK38L | 0.22232339 |
| 136 | PDGFRB | 0.22000185 |
| 137 | TTK | 0.21745544 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Mineral absorption_Homo sapiens_hsa04978 | 3.72043114 |
| 2 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.67359869 |
| 3 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.18259603 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.71574029 |
| 5 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.57416233 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.45710069 |
| 7 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.26538608 |
| 8 | Other glycan degradation_Homo sapiens_hsa00511 | 1.99983400 |
| 9 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.96360680 |
| 10 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.80617554 |
| 11 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.74240147 |
| 12 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.62041432 |
| 13 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.60709902 |
| 14 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.60701237 |
| 15 | Bile secretion_Homo sapiens_hsa04976 | 1.55469177 |
| 16 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.55299574 |
| 17 | Pertussis_Homo sapiens_hsa05133 | 1.53131318 |
| 18 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.50973401 |
| 19 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.50814836 |
| 20 | Thyroid cancer_Homo sapiens_hsa05216 | 1.49512095 |
| 21 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.48847298 |
| 22 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.42120777 |
| 23 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.41003385 |
| 24 | Sulfur relay system_Homo sapiens_hsa04122 | 1.38380698 |
| 25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.37042816 |
| 26 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.24094368 |
| 27 | Amoebiasis_Homo sapiens_hsa05146 | 1.19364340 |
| 28 | Bladder cancer_Homo sapiens_hsa05219 | 1.18100920 |
| 29 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.15921561 |
| 30 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.15676899 |
| 31 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.15240625 |
| 32 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.15228475 |
| 33 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.12788008 |
| 34 | Salivary secretion_Homo sapiens_hsa04970 | 1.12288293 |
| 35 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.11941123 |
| 36 | Galactose metabolism_Homo sapiens_hsa00052 | 1.11447909 |
| 37 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.10307724 |
| 38 | Adherens junction_Homo sapiens_hsa04520 | 1.10021030 |
| 39 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.09538523 |
| 40 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.08764402 |
| 41 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.03447285 |
| 42 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.01735368 |
| 43 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.01554145 |
| 44 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.01000229 |
| 45 | Tight junction_Homo sapiens_hsa04530 | 0.98226592 |
| 46 | Retinol metabolism_Homo sapiens_hsa00830 | 0.94235105 |
| 47 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.93674551 |
| 48 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.93079680 |
| 49 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.92570369 |
| 50 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.91583390 |
| 51 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.91537544 |
| 52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.90742904 |
| 53 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.90058867 |
| 54 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.87798172 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.87699126 |
| 56 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.86435827 |
| 57 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.86193019 |
| 58 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.86129662 |
| 59 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.85446483 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 0.85058581 |
| 61 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.83226644 |
| 62 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.78383910 |
| 63 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.78025768 |
| 64 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.77890311 |
| 65 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.77169278 |
| 66 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.74867144 |
| 67 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.73334393 |
| 68 | Focal adhesion_Homo sapiens_hsa04510 | 0.71082773 |
| 69 | Leishmaniasis_Homo sapiens_hsa05140 | 0.69732237 |
| 70 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.68097819 |
| 71 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.67620969 |
| 72 | Prion diseases_Homo sapiens_hsa05020 | 0.67336258 |
| 73 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.66948605 |
| 74 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.66755866 |
| 75 | Salmonella infection_Homo sapiens_hsa05132 | 0.65940940 |
| 76 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.65878936 |
| 77 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.64076211 |
| 78 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.63844821 |
| 79 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.63198181 |
| 80 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.63072687 |
| 81 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.62608089 |
| 82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.62473860 |
| 83 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.61367845 |
| 84 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.61364816 |
| 85 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.61219048 |
| 86 | Carbon metabolism_Homo sapiens_hsa01200 | 0.61187945 |
| 87 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.60978958 |
| 88 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.60022729 |
| 89 | Hepatitis C_Homo sapiens_hsa05160 | 0.58660193 |
| 90 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.58358490 |
| 91 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.57569852 |
| 92 | Platelet activation_Homo sapiens_hsa04611 | 0.56706814 |
| 93 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.56558311 |
| 94 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.56205935 |
| 95 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.56115753 |
| 96 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.55900700 |
| 97 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.55762020 |
| 98 | Endocytosis_Homo sapiens_hsa04144 | 0.53065537 |
| 99 | Renin secretion_Homo sapiens_hsa04924 | 0.52370000 |
| 100 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.52206376 |
| 101 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.51919101 |
| 102 | Apoptosis_Homo sapiens_hsa04210 | 0.50071257 |
| 103 | Influenza A_Homo sapiens_hsa05164 | 0.49987760 |
| 104 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.46401515 |
| 105 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.44884029 |
| 106 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.44726629 |
| 107 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.44563717 |
| 108 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.44544806 |
| 109 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.44308675 |
| 110 | Malaria_Homo sapiens_hsa05144 | 0.44152165 |
| 111 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.44118091 |
| 112 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.43466299 |
| 113 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.43254522 |
| 114 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.40922365 |
| 115 | Melanogenesis_Homo sapiens_hsa04916 | 0.40583080 |
| 116 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.38779689 |
| 117 | Endometrial cancer_Homo sapiens_hsa05213 | 0.38775305 |
| 118 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.38555088 |
| 119 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.36067578 |
| 120 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.35779601 |
| 121 | Insulin resistance_Homo sapiens_hsa04931 | 0.35649046 |
| 122 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.34997276 |
| 123 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.34668911 |
| 124 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.34461322 |
| 125 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.33304897 |
| 126 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.32610437 |
| 127 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.31830099 |
| 128 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.30694461 |
| 129 | Axon guidance_Homo sapiens_hsa04360 | 0.30215908 |
| 130 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.29581643 |
| 131 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.29192787 |
| 132 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.28470210 |
| 133 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.28253677 |
| 134 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.28228644 |

